examined the possible existence of excitatory cholinergic innervation in isolated rabbit portal vein. Longitudinal strips of the vein in the presence of both phenoxybenzamine, an a-adrenoceptor antagonist, and NG-nitro-L-arginine, an inhibitor of nitric oxide synthase, exhibited a small contraction in response to transmural electrical stimulation (ES). The contractile response to ES was augmented by physo stigmine, an anticholinesterase agent, and inhibited by atropine. These findings indicate the existence of an excitatory cholinergic innervation in addition to the known adrenergic and non-adrenergic, non-cholinergic innervations in the rabbit portal vein.
It has become evident that the blood vessel has adrener gic and cholinergic innervations as well as non-adrener gic, non-cholinergic (NANC) innervation (see ref. 1 ). However, it is also evident that there are remarkable regional differences in the features of innervation in the blood vessel system. Especially, the functional cholinergic neural supply to blood vessels has been a subject of con troversy (1, 2) . It is widely believed that the release of acetylcholine (ACh) from autonomic nerves in those tis sues that receive a cholinergic innervation dilates blood vessels (see ref.
3). Cholinergic neurogenic dilatations of arteries seem to be mostly dependent on the endothelium, with some exceptions (4). On the other hand, only a few examples of mammalian blood vessels have been reported to contract in response to cholinergic neurogenic stimula tion (2). Yoshioka et al. (5) have shown that canine portal vein has excitatory cholinergic innervation. However, it has not yet been demonstrated that rabbit portal vein has cholinergic innervation. The rabbit portal vein has previ ously been shown to have massive adrenergic and NANC innervations (6), and Brizzolara et al. (7) have very recent ly reported that the NANC nerve in rabbit portal vein con tains both nitric oxide (NO) and ATP. Utilizing the cur rently available pharmacological tools, the possibility of cholinergic excitatory innervation of the longitudinal mus cle of rabbit portal vein was reexamined in the present study.
Male White Japanese rabbits, weighing 2.0-3.0 kg, were anesthetized with pentobarbital sodium at the dose of 35 mg/kg, i.v. and exsanguinated. A section of the por tal vein was dissected and cut into two equal longitudinal strips. In some experiments, the endothelium was re moved by gently rubbing the strip with a piece of cotton wool moistened with Krebs' bicarbonate solution. The venous preparations, about 3 mm in width and 10 mm in length, were mounted vertically between a pair of plati num electrodes separated by a distance of 5 mm, suspend ed in tissue baths containing Krebs' solution aerated with 95% 02+5% CO2 and maintained at 371C, and given a load of 0.5 g. Results are expressed as means±S.E.M., and "n" refers to the number of animals. Electrical stimulation primarily produced prominent contraction of the rabbit portal vein, which was remark ably depressed by 3 x 10-8 M phenoxybenzamine, an a adrenoceptor antagonist (Fig. 1) . As shown in Fig. 1 , 10-4 M NG-nitro-L-arginine, an inhibitor of NO synthase, potentiated the remaining small contractile response to ES, and successive 3 x 10-' M physostigmine, an anti cholinesterase agent, further augmented the contraction. Thus the augmented contractile response to ES was markedly depressed by 10-'M atropine (Fig. 1) .
When the vein was previously contracted by 1 8 x 10-E M ergotamine, ES relaxed the vein frequency-dependently (data not shown). The relaxation was revealed to be NANC in nature (6). In contrast to the results of Briz zolara et al. (7), the NANC nerve-mediated relaxation was almost completely abolished by an inhibitor of NO synthase, but suramin, a P2-purinoceptor antagonist, hardly affected the relaxation (Y. Mutsukado and H. Tsuru, unpublished observation). Thus, although the reason why there was a remarkable discrepancy between their experiments and ours could not be elucidated, it seems likely that ATP might not be involved in the NANC nerve-mediated relaxation under the present condi tion.
As shown in Fig. 2 , in the presence of both 3 x 10-8 M phenoxybenzamine and 10-4 M NG-nitro-L-arginine, the remaining small contractile response to ES was augment ed by 3 x 10-' M physostigmine and inhibited by 10-' M atropine. Almost all the frequency-dependent contractile responses to ES were abolished by 10-6 M tetrodotoxin. The contractile responses to ES and exogenous ACh were not influenced by rubbing the endothelium.
The ES frequency-response curve was constructed at frequencies between 1 and 50 Hz in the presence of a adrenoceptor blockade and inhibitors of NO synthase and ACh esterase under conditions similar to those in Fig. 2 . The median effective frequency (EF50) was 6.5 ± 1.0 Hz (n = 6) and the maximum response to ES was 72.5±2.907o of the ACh-induced maximum contraction (2. 53±0.29 g, n=6) .
In addition to the adrenergic innervation, Hughes and Vane (6) described NANC nerve-mediated relaxation of the rabbit portal vein, although they did not mention any transmitter candidate for the NANC nerve. In this regard, Burnstock et al. (8) proposed that ATP might be a transmitter candidate for the NANC nerve. Recently, Toda and Okamura (9) and Bult et al. (10) have shown that NO is an inhibitory NANC neurotransmitter in the cerebral artery of some mammalian species and the ca nine ileocolonic junction, respectively. Very recently, Briz zolara et al. (7) concluded that both NO and ATP are in volved in the NANC nerve in rabbit portal vein. Indeed, N'-nitro-L-arginine, an inhibitor for NO synthase, aug mented the remaining response to ES after a-adrenocep tor blockade (Fig. 1) . The augmented contractile response to ES was further potentiated by physostigmine, an inhibi tor of ACh esterase, as shown in Fig. 1 . This potentiation could not be shown without the inhibition of NO synthe sis (data not shown). The inhibition of the prominent vasodilative action of NO nerve seems to be a key to ob serve the excitatory cholinergic action in the portal vein of the rabbit in contrast to the dog (5). These findings indicate the existence of an excitatory cholinergic innervation in addition to the known excitatory adrenergic and inhibitory NANC inner vations in rabbit portal vein. Brayden and Bevan (4) found that the posterior auricu lar artery of the cat has muscarinic receptors located directly on its smooth muscle cells that mediate smooth muscle cell relaxation, when activated by ACh released from perivascular nerves. Thus, the subtypes of musca rinic receptors located on the vascular smooth muscle cells that mediate neurogenic cholinergic dilatation and contraction remain to be characterized.
With regard to the distribution of cholinergic innerva tion in the circulatory system and its implication, we have presented a view that some of the differences in vascular characteristics between the two groups, i.e., one, a viscer al part derived from inner tube of the embryonic body, and the other, a somatic part derived from outer tube, are of embryological origin (5). Namely, it is probable that the visceral coelomic epithelium is the common origin of the smooth muscles of both the digestive tube and the por tal vein, and thus, the responses of these tissues to cholinergic impulses are in common predominantly con strictor. The present finding of excitatory cholinergic in nervation in the rabbit portal vein further supports this view.
